KRAS and familial pancreatic carcinoma: In particular, KRAS activation in pancreatic cancer, also acting as a master regulator, has been reported to promote cancer progression by influencing the properties of several tumor microenvironment components and by recruiting fibroblasts, macrophages, neutrophils, and lymphocytes, among other cells [12].